Dear Friend,

There was big news in Congress today that I wanted you to know about. A proposed government spending bill released today eliminated a provision that has protected the marijuana industry from federal prosecution for violating the Controlled Substances Act.

The Rohrabacher-Farr language was eliminated from the Commerce, Justice, Science bill that funds the Department of Justice, even though the language had previously been included in the 2017 base text. In addition, the Financial Services bill retained language preventing Washington, DC from implementing full retail sales and commercialization of recreational marijuana.

Smart Approaches to Marijuana (SAM) submitted testimony to the Appropriations Committee to push back against this provision, which has allowed unsafe and untested products to masquerade as medicine. Rather than submit their products to the FDA for approval as safe and effective medicines, the marijuana industry has instead been using medical marijuana laws as a guise to increase demand for marijuana consumption and service the black market with large amounts of high-potency marijuana.

\”If I were an investor, I would sell my marijuana stocks short,\” said Kevin Sabet, President of SAM. \”The marijuana industry has lost in every state in which they were pushing legislation in 2017, the industry\’s largest lobbying group is losing its bank account , and now they are losing protection that has helped them thrive despite marijuana\’s illegal status. Although the debate over Rohrbacher-Farr is far from over, the bad news just keeps coming for the pot industry. But it\’s great news for parents, prevention groups, law enforcement, medical professionals, victims\’ rights advocates and everyone who cares about putting public health before profits.\”

Evidence demonstrates that marijuana – which has skyrocketed in average potency over the past decade – is addictive and harmful to the human brain, especially when used by adolescents. Moreover, in states that have already legalized the drug, there has been an increase in drugged driving crashes and youth marijuana use. States that have legalized marijuana have also failed to shore up state budget shortfalls with marijuana taxes, continue to see a thriving black market, and are experiencing a continued rise in alcohol sales.

Thank you for the work that you are doing to help with these big wins for public health and safety!

Tony Coder – Director, State and Local Affairs

SAM

 

Legal Marijuana Laws Impact Youth

Researchers from Dartmouth\’s Geisel School of Medicine, whose crest is pictured above, and other academic medical institutions, surveyed 2630 14- to 18-year-olds via Facebook who live in states that have legalized marijuana for medical use (MMJ states), recreational use (RMJ states), and not legalized the drug (NMJ states).

MMJ and RMJ states vary in what they allow, and the researchers wanted to learn if different provisions influence when adolescents begin marijuana use and which provisions may result in increasing use among young people.

The researchers say it is crucial to understand how marijuana legalization laws affect youth because they are more vulnerable to the drug’s harmful effects. Chronic use during adolescence has been associated with impaired brain development, educational achievement, and psychosocial functioning, as well as an increased risk of developing addiction.

Legalization has spurred the development of new marijuana products with higher potencies, such as marijuana-infused foods called edibles and electronic vaping devices that enable a user to inhale the psychoactive ingredients of tobacco and marijuana without the smoke.

Edibles sold in most legal states lack safety standards or products regulations and are marketed in ways that are attractive to youth, the researchers note. These factors are contributing to the sharp increase in marijuana overdoses among young people. Vaping devices are becoming increasingly popular among middle school and high school children who use them to vape marijuana more often than adults. Moreover, data show adolescents are vaping high-potency marijuana products whose impact on neurodevelopment is unknown but concerning because they may place youth at higher risk for psychosis.

The researchers find that youth in legalization states are twice as likely as those in nonlegalization states to have tried vaping. Moreover, youth in legalization states with high dispensary density are twice as likely to have tried vaping and three times more likely to have tried edibles than youth in nonlegalization states.

The kind and duration of marijuana legalization laws also impact youth. Youth in MMJ states are significantly more likely to have tried vaping and edibles than youth in nonlegalization states, and youth in RMJ states are significantly more likely to have tried both than youth in MMJ states. Youth in legal states that allow home cultivation are twice as likely to have tried edibles (but not vaping) as their peers in legal states that prohibit home grows. States with the oldest legalization laws also see increases in youth lifetime vaping and edible use.

Read Science Daily summary here. Read Drug and Alcohol Dependence journal abstract here.

http://themarijuanareport.org/

Pay to Play: Congressional Cannabis Caucus and Colleagues–More Tracking the Money

Three months ago, National Families in Action published a report, Tracking the Money that is Legalizing Marijuana and Why It Matters, that details where the money comes from to legalize marijuana for medical and recreational use. Most of it was raised by three billionaires and two organizations they fund, the Drug Policy Alliance (DPA) and the Marijuana Policy Project (MPP) to do the work of legalization. The first decade of legalization was accomplished via ballot measures which DPA and/or MPP wrote, paid for collecting voters’ signatures, and paid heavily for advertising with less than accurate information to convince voters to pass them. This effort created a medical marijuana industry that made so much money it began contributing to the legalization effort as well.

In February 2017, five US Representatives formed the Congressional Cannabis Caucus to issue a spate of bills that would set the stage and then ultimately legalize marijuana at the federal level. It turns out that DPA and MPP donations to Congressional campaigns are over-represented among Caucus members and other legislators who are partnering with them to reach this goal. Together, Caucus members, pictured above, and colleagues have introduced more than 20 bills since February.

Rep. Earl Blumenauer (D-OR), who received $3,000 from MPP, has introduced three of those bills and is co-sponsoring seven more.

Rep. Ed Perlmutter (D-CO) received $2,000 from MPP, has introduced one bill, and co-sponsored four more.

Rep. Ed Polis (D-CO), the only Caucus member who has not received donations from either group, has introduced one bill and co-sponsored six more.

Rep. Young (R-AK) received $1,000 from MPP, introduced one bill, and co-sponsored five more.

Rep. Dana Rohrabacher (R-CA) received $7,000 from MPP and $4,700 from DPA, introduced one bill, and co-sponsored five more bills.

Here are the representatives and senators who signed on as co-sponsors of the 20-plus bills who also received donations from DPA and/or MPP as of June 28:

  • Rep. Ruben Gallego (D-AZ) — $5,000/MPP — co-sponsoring 1 bill.
  • Rep. Raul Grijalva (D-AZ) — $1,000/MPP — co-sponsoring 2 bills.
  • Rep. Pete Aguilar (D-CA) — $8,000/MPP — co-sponsoring 1 bill.
  • Rep. Jared Huffman (D-CA) — $3,000/MPP — co-sponsoring 2 bills.
  • Rep. Duncan Hunter (R-CA) — $1,000/MPP — co-sponsoring 3 bills.
  • Rep. Barbara Lee (D-CA) — $4,500/MPP/$500/DPA — sponsoring 1 bill, co-sponsoring 5 bills.
  • Rep. Alan Lowenthal (D-CA) — $1,000/MPP — co-sponsoring 1 bill.
  • Rep. Mike Coffman (R-CO) — $1,000/MPP — sponsoring 1 bill, co-sponsoring 3 bills.
  • Rep. Diana DeGette (D-CO) — $1,000/DPA — sponsoring 1 bill, co-sponsoring 2 bills.
  • Rep. Joe Courtney (D-CT) — $2,600/MPP — co-sponsoring 2 bills.
  • Rep. Carlos Curbelo (R-FL) — $1,000/MPP — co-sponsoring 1 bill.
  • Rep. Ted Yoho (R-FL) — $1,000/MPP — co-sponsoring 1 bill.
  • Rep. Thomas Massie (R-KY) — $1,000/MPP — co-sponsoring 1 bill.
  • Sen. Rand Paul (R-KY) — $3,500/MPP — co-sponsoring 3 bills.
  • Rep. Jamie Raskin (D-MD) — $5,000/MPP — co-sponsoring 2 bills.
  • Rep. Justin Amash (R-MI) — $5,750/MPP/$1,000/DPA — co-sponsoring 3 bills.
  • Rep. John Conyers (D-MI) — $2,500/DPA — co-sponsoring 1 bill.
  • Sen. Roy Blunt (R-MO) — $1,000/MPP — co-sponsoring 1 bill.
  • Rep. Ruben Kihuen (D-NV) — $1,00/MPP — co-sponsoring 2 bills.
  • Sen. Cory Booker (D-NJ) — $1,000/DPA — sponsoring 1 bill.
  • Rep. Steve Cohen (D-TN) — $5,500/MPP – sponsoring 1 bill, co-sponsoring 7 bills.
  • Rep. Jim Cooper (D-TN) — $1,000/MPP — co-sponsoring 1 bill.
  • Rep. Beto O’Rourke (D-TX) — $6,000/MPP/$4,500/DPA — co-sponsoring 5 bills.
  • Rep. Mark Pocan (D-WI) — $4,000/MPP — co-sponsoring 3 bills.
  • Sen. Tammy Baldwin (D-WI) — $1,500/MPP — co-sponsoring 1 bill.

People who don’t want to see Congress legalize marijuana nationwide can pay to play too. With few exceptions, these are not large amounts of money. They could be matched to replace MPP’s and DPA’s donations so legislators can work for healthy families and healthy communities instead of the marijuana industry.

The Cannabist, the Denver Post’s marijuana website, published a list of bills these folks have introduced in Congress since the Caucus was formed in February. You can read it here. Note: a few bills in the list do not deal with legalization.

 

 

SAM Press Office [email protected] (571) 358-8070

Today, Smart Approaches to Marijuana President and former White House advisor Kevin Sabet released this statement on Nevada\’s plan to defy federal law and commercialize the retail sales of marijuana:

\”Nevada\’s legislators say they want to be a marijuana tourism destination, but they failed to consult the Netherlands. The Dutch found out tying pot to tourism is a terrible idea, and passed a law in 2012 to ban the sale of marijuana to tourists.

\”Further, the Dutch believe no one would be stupid enough to allow the for-profit marketing and commercialization of marijuana, edibles, and high-potency extracts. But that\’s just what states like Colorado and Nevada have done.

\”Nevada\’s tax authority had to issue an emergency regulation to stop the sales of existing \’medical marijuana\’ lollipops and ice cream. Belatedly, state regulators recognized that radically increasing the availability of these products was going to land more kids in the emergency room, just as it has in Colorado. But the state law still allows the sale of 98% concentrated \’dabs,\’ which are very dangerous for the average user.

\”Legalization has not reduced the black market, as we have seen that 70% of all transactions in Oregon still occur on the black market. The Colorado AG noted this week that, \’The black market for marijuana has not gone away since recreational marijuana was legalized in our state, and in fact continues to flourish.\’ Taxing marijuana has not fixed state budgets in other states.

\”The legalized industry has become this generation\’s predatory Big Tobacco, converting young customers into lifelong profit centers. Nevada will face the same increases in drugged-driving fatalities and emergency room visits as other legalized states. We are working with employers and health care professionals in the state to minimize the damage to public health from these misguided laws.\”

Evidence demonstrates that marijuana – which has skyrocketed in average potency over the past decade – is  addictive and harmful to the human brain, especially when used by adolescents. Moreover, in states that have already legalized the drug, there has been an increase in drugged driving crashes and youth marijuana use. States that have legalized marijuana have also failed to shore up state budget shortfalls with marijuana taxes, continue to see a thriving black market, and are experiencing a continued rise in alcohol sales.

 

 

Press Release

Contact: DEA Public Affairs (202) 307-7977

China announces scheduling controls of new psychoactive substances/fentanyl-class substances

 

JUN 20 – (Washington, D.C.) — China\’s National Narcotics Control Commission today announced scheduling controls against four new psychoactive substances/fentanyl-class substances – U-47700, MT-45, PMMA, and 4,4\’ DMAR. The scheduling controls will take effect on July 1, 2017. This announcement is the culmination of ongoing collaboration between the Drug Enforcement Administration and the Government of China, and reaffirms the shared commitment to countering illicit new psychoactive substances.
\”Fentanyl compounds are a large and deadly portion of the current opioid crisis. The Chinese scheduling actions will help save lives, and I truly appreciate these important steps,\” said DEA Acting Administrator Chuck Rosenberg. \”Our countries need to continue to work together on this epidemic, however and wherever possible.\”

DEA and Chinese officials have met regularly to discuss the threat from fentanyl class substances. Representatives from the China National Narcotics Laboratory, the Narcotics Control Bureau, and the Ministry of Public Security met with DEA officials to exchange information on emerging substances scientific data, trafficking trends, and sample exchanges. This dialogue resulted in improved methods for identifying and submitting deadly substances for government control.

U-47700 a synthetic opioid, also known as \”pink,\” has no medical use and was emergency scheduled (Scheduled I) in the United States on November 14, 2016.

China\’s National Narcotics Control Commission previously controlled four fentanyl-class substances – carfentanil, furanyl fentanyl, valeryl fentanyl, and acryl fentanyl which took effect on March 1, 2017.

 

 

Statement by President of Smart Approaches to Marijuana on Senators Booker and Gillibrand\’s Marijuana Legislation to Bypass FDA

Today, Dr. Kevin Sabet, president of Smart Approaches to Marijuana (SAM), a national group promoting evidence-based marijuana laws, issued the following statement regarding medical marijuana legislation introduced by Senators Booker (D-NJ) and Gillibrand (D-NY) and Rep. Steve Cohen (D-TN):

\”No one wants to deprive chronically ill patients of medication that could be helpful for them, but that\’s not what the legislation being introduced today is about. We wouldn\’t allow Pfizer to bypass the FDA – why would we let the marijuana industry? This bill would completely undermine the FDA approval process, and encourage the use of marijuana and marijuana products that have not been proven either safe or effective. The FDA approval process should set the standard for smart, safe, and sound healthcare in our country, so we can be sure that patients are receiving the best treatments that do more help than harm,\” said SAM President and former senior White House drug policy advisor Kevin Sabet.

\”Raw marijuana is not medicine, so marijuana in crude form should not be legal, but the medicinal components properly researched, purified, and dosed should be made available through compassionate research programs, as outlined in SAM\’s six-point plan entitled \”Researching Marijuana\’s Medical Potential Responsibly.\” We understand the FDA process can seem cumbersome to those suffering from intractable diseases, but early access programs to drugs in development are already available.

\”Also, while FDA approval is the long-term goal, seizure patients shouldn\’t have to go to the unregulated market to get products full of contaminants. Responsible legislation that fast-tracks these medications for those truly in need should be supported, rather than diverting patients to an unregulated CBD market proven to be hawking contaminated or mislabeled products as medicine, as this bill would endorse. In 2015 and 2016 the FDA sent multiple warning letters to numerous CBD manufacturers, outlining these concerns. We support the development of FDA-approved CBD medications, like Epidolex, which is in the final stages of approval.\”

News media requesting a one-one-one interview with a representative from SAM can contact [email protected].

 

I wanted to make sure you saw the latest evidence that corporate interests are looking to take over the legal marijuana industry.  According to a report published in the Boston Globe today, wholesalers involved in delivering and taxing cigarettes in Massachusetts are now trying to take advantage legal marijuana so they can create their own marijuana monopoly.  According to the Globe:

\”Plenty of companies are angling to get in on the coming legalized pot bonanza. Some, however, are lobbying the state to carve off a piece just for them: cigarette wholesalers.

The companies that track, deliver, and tax all the cigarettes sold in Massachusetts are seeking a similar monopoly on recreational marijuana when sales begin in 2018. They\’ve asked state officials to require marijuana producers to sell all their pot products through them – just as most alcohol has to pass through a wholesaler on its way to bars and package stores.\”

Will you help us stand up to the next Big Tobacco industry in Massachusetts and across America?

If you haven\’t already, consider downloading the SAM app. With the app, you can stay connected on the latest news from SAM and take action to contact elected officials who are considering marijuana-related legislation. You can connect with other like-minded activists committed to making our communities healthy and safe. The app is free and available for download in the Apple App store and on Google Play.

Keep up the fight,

Kevin

www.learnaboutsam.org

 

V PADMAJA June 04,2017

58 year old Rakesh* was in his early twenties when he first took to the bottle. His drinking slowly spiraled out of control and he became a full-blown addict. Alcoholism began affecting his mental health and strained his relationship with his family. Not only was his personal life in shambles, his drinking took a toll on his career too.

Despite being a graduate of Shree Ram College of Commerce; he ended up in a job that paid him close to nothing. After struggling for nearly two decades, he finally decided to seek help. He joined Alcoholics Anonymous (AA) in 1996 and has been sober for 18 years now.

Like Rakesh, many addicts in India have turned to Alcoholic Anonymous groups to get back on the road to sobriety.

AA is a voluntary, non-profit society of recovering alcoholics founded in 1935 in the United States of America. It was established with a purpose of combating alcoholism, considered a moral sin at that time. Since then, AA has evolved into a holistic recovery program for alcoholics with a strong global network. It claims to have a membership of over 30 lakh alcoholics worldwide and 40,000 sober alcoholics in India alone.

The group relies on a ‘12 step programme’ for recovery and adheres strictly to the principle of maintaining anonymity. Through anonymity the society ensures the creation of a safe space for its members and protects their reputation from any stigma that maybe associated with addiction.

For more http://www.thecitizen.in/index.php/OldNewsPage/?Id=10884&Sobriety/Through/Anonymity:/How/AA/Groups/Help/Alcoholics/Battle/Addiction

 

Teenage rugby player cut off penis while high on skunk, says father who wants drug made Class A 2 JUNE 2017

The teenager\’s father is backing Lord Monson\’s call for skunk to be reclassified  CREDIT:MATTHEW FEARN/PA WIRE

Ateenage rugby player cut off his own penis and stabbed his mother while high on skunk, his father has revealed, as he called for the drug to be reclassified.

The father, named only as Nick because he wants to remain anonymous as his son is rebuilding his life, is backing Lord Nicholas Monson\’s campaign to have skunk reclassified from a class B to a class A drug and for the traditional weaker form of cannabis to be decriminalised.

Lord Monson launched his call following the suicide of his 21-year-old son Rupert, who was addicted to skunk.

For more http://www.telegraph.co.uk/news/2017/06/02/teenage-rugby-player-cut-penis-high-onskunk-says-father-wants/

 

May 2017

Adults who have used tobacco and currently use marijuana are twice as likely as those who have never used marijuana to be continued tobacco users, according to a new study from the University of Washington School of Public Health. About 70 percent of adult marijuana users are also tobacco users, which may complicate tobacco cessation…“We do not yet know how the widespread legalization of marijuana for recreational or non-medical purposes will impact tobacco use and cessation,” said lead author Gillian Schauer, clinical instructor of health services at the School. “Tobacco use is still the number one cause of preventable death and disease in this country, and the overlap between tobacco use and marijuana use is substantial. If using marijuana makes it harder to quit tobacco, it could have important implications for tobacco control efforts.”

For More http://sph.washington.edu/news/article.asp?content_ID=8474

 

Scroll to Top